BHB in Applied Metabolic Nutrition
SIAN’s first special focus meeting convened leading international speakers to examine the present and future role of beta-hydroxybutyrate in applied metabolic nutrition. This page preserves the meeting programme, faculty, and supporting detail as an archival record of the institute’s inaugural convening.
Programme at a glance
| Session I — Keynote & Core Science | |
| Welcome & Introduction: SIAN Faculty Mission | Dr. Richard Littlewood (UK) & Dr. Jun Tsubota (JP) |
| Keynote: The BHB Journey; What Is Its Full Potential? | Dr. Mary Newport (USA) |
| BHB and Performance | Dr. Jacob Wilson (USA) |
| Functional Effects of Oral BHB on Attention and Mental Fatigue in Healthy Adults | Mr. Satoshi Morita (JP) |
| Session II — Specialised Applications | |
| The Metabolic Face of Migraine and Potential Protective Mechanisms of Ketone Bodies | Dr. Elena Gross (CH) |
| BHB, Exercise and Long-term Brain Health | Prof. J. Walsh (CA) |
| Session III — Workshop: Supply, Regulation & Legal | |
| Key Observations: BHB Potential | Gary Millet (USA) & Rob Rogers (USA) |
| Innovation in BHB Biosynthesis & Industrial Supply | Dr. Jun Tsubota (JP) |
| Global Standards: Navigating the Regulatory Landscape | Dr. Richard Littlewood (UK) |
| Session IV — Specialised Applications 2 | |
| BHB in Practice: Management of Diabetes and Hypoglycaemia | Prof. Dr. D. Russell-Jones (UK) |
| BHB Transforms Outcomes in Polycystic Kidney Disease | Prof. Thomas Weimbs (USA) |
| Closing Keynote | |
| Exogenous Ketones: Emerging Science, Clinical Applications, and the Case for Research Rigor | Prof. Dominic D'Agostino (USA) |
| Conclusions | Dr. Richard Littlewood & Dr. Jun Tsubota |
The organising team thanks Prof. Ben Bikman, Prof. Dr. Christina Heidt, Dr. Ryley Parrish, Dr. Soto Mota, and Dr. Andrew Koutnik for their support and looks forward to their participation in future meetings.
Academic speakers and advisors
Prof. Dominic D'Agostino (USA)
University of South Florida / IHMC
Leading expert in neuroprotection, oxygen toxicity, and metabolic therapies.
Dr. Elena Gross (CH)
KetoSwiss / University of Basel
Specialist in clinical neuroscience and the metabolic management of chronic migraine.
Dr. Richard Littlewood (UK)
Flow Health Science
Inventor of Klario (BHB product for diabetes hypos).
Mr. Satoshi Morita (JP)
Suntory Global Innovation Center
Specialist in the cognitive benefits of metabolic signalling metabolites.
Dr. Mary Newport (US)
TriVital Therapeutics
Pioneer in ketone therapies for neuroprotection and cellular energy.
Prof. Dr. D. Russell-Jones (UK)
University of Surrey
Clinical expert in diabetes, including BHB applications.
Dr. Jun Tsubota (JP)
Osaka Gas Co., Ltd
Expert in microbial production of BHB.
Prof. J. Walsh (CA)
McMaster University
Specialist in the influence of exercise and exogenous ketones on long-term brain health and cognition.
Prof. Thomas Weimbs (USA)
University of California, Santa Barbara
Leads research on the molecular mechanisms and treatment of polycystic kidney disease.
Dr. Jacob Wilson (USA)
ASPI Tampa
Specialist in BHB effects on body composition & muscle protein synthesis.
Sponsors & Partners
Lead Sponsor
With Support From